Angela Steinway

Ms. Steinway brings over 20 years of experience in the medical device industry, having worked in various strategy, sales and finance functions throughout her career. Currently, she is the Vice President, Corporate Development at Dexcom where she oversees Dexcom’s M&A and strategic partnership activities. Prior to joining Dexcom last year, Ms. Steinway spent 14 years at Integra LifeSciences Corporation, where she held roles of increasing responsibility within the company’s finance and sales organizations, and most recently led strategy and business development for the tissue technologies division and managed a $120 million business serving non-core commercial markets. Earlier in her career, Ms. Steinway worked at Oppenheimer & Co (formerly CIBC World Markets) as a Securities Analyst, Medical Devices & Diagnostics Equity Research where her research focused on the medical technology industry. Ms. Steinway earned her B.A. in Economics from the University of Pennsylvania and holds an Executive Education Certificate from the Wharton School of the University of Pennsylvania. She is an active angel investor and member of NuFund, occasionally leading deals as part of the Life Sciences committee. She currently sits on the board of ProduceGood, a nonprofit organization dedicated to finding sustainable solutions to alleviate hunger, reclaim and repurpose waste and promote community health.